NCT00197756

Brief Summary

The purpose of this study is to analyze stored samples and data collected during the conduct of the study "A Trial of Vitamins in HIV Progression and Transmission" (HD32257). The aims are to examine the effect of vitamin supplementation on HIV infected women during pregnancy on a number of parameters in breastmilk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
771

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2004

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2004

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

September 12, 2005

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 20, 2005

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2007

Completed
Last Updated

August 21, 2009

Status Verified

August 1, 2009

Enrollment Period

2.9 years

First QC Date

September 12, 2005

Last Update Submit

August 20, 2009

Conditions

Keywords

HIVBreastfeedingVitaminsTanzaniaChildren

Outcome Measures

Primary Outcomes (3)

  • cell-free viral load and/or cell-associated proviral load in breast milk

    Delivery, 3 months, and 6 months after delivery

  • concentration of vitamins A, B12, and E in breast milk

    Delivery, 3 months, and 6 months post-delivery

  • subclinical mastitis

    Delivery, 3 months, and 6 months after delivery

Secondary Outcomes (4)

  • post-natal mother-to-child transmission of HIV

    Delivery, 3 months, and 6 months post-delivery

  • infant mortality and morbidity from diarrhea

    Delivery, 3 months and 6 months after delivery

  • a.) CCR5 expression in differentiating monocytes and differentiated monocyte-derived macrophages

    N/A (in vitro experiment)

  • HIV-1 replication in differentiating monocytes acutely infected with a subtype C HIV-1 clone, differentiated non-dividing MDMs acutely infected with the HIV-1 MJ4 clone, and differentiated non-dividing MDMs chronically infected with the HIV-1 MJ4 clone.

    N/A (in vitro experiment)

Study Arms (4)

Vitamin A

Participants in the in the parent study who had been randomized to receive either Vitamin A alone or multivitamins including vitamin A.

Dietary Supplement: Vitamin A alone

No Vitamin A

Participants in the parent study who were randomized to receive either multivitamins excluding vitamin A, or placebo.

Dietary Supplement: Multivitamins excluding vitamin ADietary Supplement: multivitamins including vitamin AOther: Placebo

Multivitamins

Participants in the parent study who were randomized to receive multivitamins including vitamin A or multivitamins excluding vitamin A

Dietary Supplement: Vitamin A aloneDietary Supplement: Multivitamins excluding vitamin ADietary Supplement: multivitamins including vitamin A

No Multivitamins

Participants from the parent study who had been randomized to vitamin A alone or placebo

Dietary Supplement: Vitamin A aloneOther: Placebo

Interventions

Vitamin A aloneDIETARY_SUPPLEMENT

30 mg beta-carotene plus 5000 IU preformed vitamin A) taken orally once per during pregnancy and lactation

MultivitaminsNo MultivitaminsVitamin A

30 mg thiamine, 20 mg riboflavin, 20 mg B-6, 100 mg niacin, 50 ug vitamin B-12, 500 mg vitamin C, 30 mg vitamin E, 0.8 mg folic acid taken orally once per day during pregnancy and lactation

MultivitaminsNo Vitamin A

20 mg thiamine, 20 mg riboflavin, 25 mg vitamin B6, 100 mg niacin, 50 ug vitamin B12, 500 mg vitamin C, 30 mg vitamin E, and 0.8 mg folic acid taken once per day orally during pregnancy and lactation

MultivitaminsNo Vitamin A
PlaceboOTHER

Placebo pill taken orally once per day during pregnancy and lactation

No MultivitaminsNo Vitamin A

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The data and samples used in this study are from HIV-infected pregnant women who participated in the "Trial of Vitamins in HIV Transmission and Progression". Between 1995 and 1997, 1,078 African, HIV positive women who were between gestatopm weeks 12 and 27 were recruited. They were followed until August 2003. This study was conducte among 771 of these women, for whom breast milk samples were available at delivery. There were no differences in baseline characteristics between this subset and the originally randomized group of 1,069.

You may qualify if:

  • HIV infected women presenting to antenatal care between 12 and 27 weeks of gestation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Harvard School of Public Health

Boston, Massachusetts, 02115, United States

Location

Related Publications (2)

  • Villamor E, Koulinska IN, Aboud S, Murrin C, Bosch RJ, Manji KP, Fawzi WW. Effect of vitamin supplements on HIV shedding in breast milk. Am J Clin Nutr. 2010 Oct;92(4):881-6. doi: 10.3945/ajcn.2010.29339. Epub 2010 Aug 25.

  • Webb AL, Aboud S, Furtado J, Murrin C, Campos H, Fawzi WW, Villamor E. Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women. Eur J Clin Nutr. 2009 Mar;63(3):332-9. doi: 10.1038/sj.ejcn.1602929. Epub 2007 Oct 17.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Breast milk samples collected from breast at delivery and at 3 month intervals thereafter.

MeSH Terms

Conditions

Breast Feeding

Interventions

Vitamin A

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

RetinoidsCarotenoidsPolyenesAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsCyclohexenesCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicTerpenesDiterpenesPigments, BiologicalBiological Factors

Study Officials

  • Eduardo Villamor, MD,DrPH

    Harvard School of Public Health (HSPH)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 12, 2005

First Posted

September 20, 2005

Study Start

September 1, 2004

Primary Completion

August 1, 2007

Study Completion

August 1, 2007

Last Updated

August 21, 2009

Record last verified: 2009-08

Locations